Hongwei Xia
- Molecular Biology top 10%
- Cancer Research top 2%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Surgery
- Topics
- Cancer-related molecular mechanisms research (12 papers)MicroRNA in disease regulation (10 papers)Hippo pathway signaling and YAP/TAZ (9 papers)
- Journals
- The LancetPLoS ONEScientific Reports
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Hongwei Xia
66 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 1.1k
- Cancer Research 828
- Oncology 427
- Pulmonary and Respiratory Medicine 267
- Surgery 241
Countries citing papers authored by Hongwei Xia
This map shows the geographic impact of Hongwei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Xia more than expected).
Fields of papers citing papers by Hongwei Xia
This network shows the impact of papers produced by Hongwei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Xia. The network helps show where Hongwei Xia may publish in the future.
Co-authorship network of co-authors of Hongwei Xia
This figure shows the co-authorship network connecting the top 25 collaborators of Hongwei Xia. A scholar is included among the top collaborators of Hongwei Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongwei Xia. Hongwei Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 21 | |
| 8 | 2 | |
| 9 | Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancerbreakdown → | 265 |
| 10 | 14 | |
| 11 | 14 | |
| 12 | 35 | |
| 13 | 1 | |
| 14 | 11 | |
| 15 | 26 | |
| 16 | 85 | |
| 17 | 39 | |
| 18 | 24 | |
| 19 | 20 | |
| 20 | 24 |
About Hongwei Xia
Hongwei Xia is a scholar working on Cancer Research, Biological Psychiatry and Cell Biology, having authored 73 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (10 papers) and Hippo pathway signaling and YAP/TAZ (9 papers). The work is most often cited by research in Cancer Research (828 citations), Molecular Biology (1.1k citations) and Oncology (427 citations). Hongwei Xia has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Qiulin Tang, Feng Bi, Feng Bi, Huanji Xu, Sheng Zhou, Gongmin Zhu, Lijiao Pei, Qiyong Gong, Weibing Leng and Guoqing Wei. Their work appears in journals such as The Lancet, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.